TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Anesthesiology Control Tower: Feedback Alerts to Supplement Treatments (ACTFAST)
Brief Summary: This study is a pragmatic, comparative effectiveness trial that will randomize approximately 12,000 adult surgical patients on an operating room (OR) level to a control or to an intervention group. All OR clinicians will have access to decision support software within the OR as a part of enhanced standard intraoperative care. The ACT will monitor patients in both groups and will provide additional support to the clinicians assigned to intervention ORs.


Options:
A: Arm Label: Cognitive Exercise; Type: EXPERIMENTAL; Interventions: Other: Mini-Mental State Examination, Other: Self-Administered Gerocognitive Examination, Other: Geriatric Depression Scale, Other: Charlson Comorbidity Index, Other: Short Form 36 Health Survey, Other: Confusion Assessment Method, Other: Memorial Delirium Assessment Scale, Other: Postoperative Quality of Recovery Scale | Arm Label: Normal Activity; Type: PLACEBO_COMPARATOR; Interventions: Other: Mini-Mental State Examination, Other: Self-Administered Gerocognitive Examination, Other: Geriatric Depression Scale, Other: Charlson Comorbidity Index, Other: Short Form 36 Health Survey, Other: Confusion Assessment Method, Other: Memorial Delirium Assessment Scale, Other: Postoperative Quality of Recovery Scale | Intervention Type: OTHER; Name: Mini-Mental State Examination; Assigned to Arm(s): Cognitive Exercise, Normal Activity | Intervention Type: OTHER; Name: Self-Administered Gerocognitive Examination; Assigned to Arm(s): Cognitive Exercise, Normal Activity | Intervention Type: OTHER; Name: Geriatric Depression Scale; Assigned to Arm(s): Cognitive Exercise, Normal Activity | Intervention Type: OTHER; Name: Charlson Comorbidity Index; Assigned to Arm(s): Cognitive Exercise, Normal Activity | Intervention Type: OTHER; Name: Short Form 36 Health Survey; Assigned to Arm(s): Cognitive Exercise, Normal Activity | Intervention Type: OTHER; Name: Confusion Assessment Method; Assigned to Arm(s): Cognitive Exercise, Normal Activity | Intervention Type: OTHER; Name: Memorial Delirium Assessment Scale; Assigned to Arm(s): Cognitive Exercise, Normal Activity | Intervention Type: OTHER; Name: Postoperative Quality of Recovery Scale; Assigned to Arm(s): Cognitive Exercise, Normal Activity
B: Intervention Type: PROCEDURE; Name: Orthogeriatric intervention; Assigned to Arm(s): N/A
C: Arm Label: Anesthesiology Control Tower Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Anesthesiology Control Tower Feedback; Type: EXPERIMENTAL; Interventions: Other: Anesthesiology Control Tower Feedback | Intervention Type: OTHER; Name: Anesthesiology Control Tower Feedback; Assigned to Arm(s): Anesthesiology Control Tower Feedback
D: Arm Label: Usual Care Group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Experimental Group; Type: EXPERIMENTAL; Interventions: Behavioral: a modified NTU-HELP | Intervention Type: BEHAVIORAL; Name: a modified NTU-HELP; Assigned to Arm(s): Experimental Group

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Anesthesiology Control Tower: Feedback Alerts to Supplement Treatments (ACTFAST)
Brief Summary: This study is a pragmatic, comparative effectiveness trial that will randomize approximately 12,000 adult surgical patients on an operating room (OR) level to a control or to an intervention group. All OR clinicians will have access to decision support software within the OR as a part of enhanced standard intraoperative care. The ACT will monitor patients in both groups and will provide additional support to the clinicians assigned to intervention ORs.


Options:
A: Arm Label: Intervention Group; Type: EXPERIMENTAL; Interventions: Other: Multicomponent nurse-led intervention | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Multicomponent nurse-led intervention; Assigned to Arm(s): Intervention Group
B: Arm Label: Usual Care Group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Experimental Group; Type: EXPERIMENTAL; Interventions: Behavioral: a modified NTU-HELP | Intervention Type: BEHAVIORAL; Name: a modified NTU-HELP; Assigned to Arm(s): Experimental Group
C: Arm Label: multifaceted prevention program; Type: EXPERIMENTAL; Interventions: Behavioral: Multifaceted prevention program HELP(Hospital Elder Life Program) | Arm Label: usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Multifaceted prevention program HELP(Hospital Elder Life Program); Assigned to Arm(s): multifaceted prevention program
D: Arm Label: Anesthesiology Control Tower Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Anesthesiology Control Tower Feedback; Type: EXPERIMENTAL; Interventions: Other: Anesthesiology Control Tower Feedback | Intervention Type: OTHER; Name: Anesthesiology Control Tower Feedback; Assigned to Arm(s): Anesthesiology Control Tower Feedback

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prevention of Aromatase Inhibitor-Induced Toxicity With Omega-3 Supplementation
Brief Summary: This clinical trial studies the use of omega-3 fatty acid supplementation in preventing aromatase inhibitor-induced toxicity in patients with stage I-III breast cancer. An omega-3 supplementation may help relieve moderate to severe bone pain and improve joint symptoms caused by aromatase inhibitor-induced arthralgias.


Options:
A: Arm Label: Hyaluronic Acid; Type: EXPERIMENTAL; Interventions: Drug: Hyaluronic Acid (HA) | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: Hyaluronic Acid (HA); Assigned to Arm(s): Hyaluronic Acid | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Arm I (omega-3 fatty acid); Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Omega-3 Fatty Acid | Arm Label: Arm II (placebo); Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Omega-3 Fatty Acid; Assigned to Arm(s): Arm I (omega-3 fatty acid) | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Arm II (placebo)
C: Arm Label: T+OFS; Type: ACTIVE_COMPARATOR; Interventions: Drug: tamoxifen, Drug: triptorelin | Arm Label: E+OFS; Type: EXPERIMENTAL; Interventions: Drug: exemestane, Drug: triptorelin | Intervention Type: DRUG; Name: exemestane; Assigned to Arm(s): E+OFS | Intervention Type: DRUG; Name: tamoxifen; Assigned to Arm(s): T+OFS | Intervention Type: DRUG; Name: triptorelin; Assigned to Arm(s): E+OFS, T+OFS
D: Intervention Type: DRUG; Name: Duloxetine; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Mobile Technology and Online Tools to Improve Asthma Control in Adolescents
Brief Summary: This project will preliminarily validate CampAir, an empirically-based dynamic e-health intervention (based on the evidence-based ASMA) to assist adolescents with uncontrolled asthma to learn how to manage their illness and improve their asthma control. In addition to developing a highly novel product for adolescents with asthma, the research proposed for this project will address unique scientific questions. Despite the high asthma prevalence among adolescents, few interventions have specifically targeted adolescents. This study is innovative in that it is among the few to focus on adolescents, who are often overlooked by the healthcare system. This research will assess factors associated with successful implementation of CampAir, thereby providing new information regarding how e-health interventions can be effectively developed and implemented for use with adolescents with asthma.


Options:
A: Arm Label: End User Iterative Testing - CampAir; Type: OTHER; Interventions: Behavioral: CampAir | Intervention Type: BEHAVIORAL; Name: CampAir; Assigned to Arm(s): End User Iterative Testing - CampAir
B: Arm Label: CampAir Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: CampAir | Arm Label: Information and Referral Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Information and Referral | Intervention Type: BEHAVIORAL; Name: CampAir; Assigned to Arm(s): CampAir Intervention | Intervention Type: BEHAVIORAL; Name: Information and Referral; Assigned to Arm(s): Information and Referral Control
C: Arm Label: I Can Cope Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: I Can Cope Intervention | Arm Label: Standard Education Intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard Education Intervention | Arm Label: No treatment control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: I Can Cope Intervention; Assigned to Arm(s): I Can Cope Intervention | Intervention Type: BEHAVIORAL; Name: Standard Education Intervention; Assigned to Arm(s): Standard Education Intervention
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Multisystemic Therapy | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Home-based, Non-Directive Family Support | Intervention Type: BEHAVIORAL; Name: Multisystemic Therapy; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Home-based, Non-Directive Family Support; Assigned to Arm(s): 2

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Mobile Technology and Online Tools to Improve Asthma Control in Adolescents
Brief Summary: This project will preliminarily validate CampAir, an empirically-based dynamic e-health intervention (based on the evidence-based ASMA) to assist adolescents with uncontrolled asthma to learn how to manage their illness and improve their asthma control. In addition to developing a highly novel product for adolescents with asthma, the research proposed for this project will address unique scientific questions. Despite the high asthma prevalence among adolescents, few interventions have specifically targeted adolescents. This study is innovative in that it is among the few to focus on adolescents, who are often overlooked by the healthcare system. This research will assess factors associated with successful implementation of CampAir, thereby providing new information regarding how e-health interventions can be effectively developed and implemented for use with adolescents with asthma.


Options:
A: Arm Label: Intervention Arm; Type: EXPERIMENTAL; Interventions: Other: ASTHMAXcel App | Arm Label: Usual Care Arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: ASTHMAXcel App; Assigned to Arm(s): Intervention Arm
B: Arm Label: CampAir Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: CampAir | Arm Label: Information and Referral Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Information and Referral | Intervention Type: BEHAVIORAL; Name: CampAir; Assigned to Arm(s): CampAir Intervention | Intervention Type: BEHAVIORAL; Name: Information and Referral; Assigned to Arm(s): Information and Referral Control
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: AsthmaNet | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: AsthmaNet; Assigned to Arm(s): 1
D: Arm Label: Reference; Type: OTHER; Interventions: Behavioral: Marketed experience application on adherence | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Marketed experience application on adherence | Intervention Type: BEHAVIORAL; Name: Marketed experience application on adherence; Assigned to Arm(s): Intervention, Reference

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: Stroke survivors, as a group, are extremely inactive and this has serious consequences for them, including an increased risk of a second stroke and developing other diseases. This study investigates a novel intervention designed to improve everyday activity after stroke by combining walking training to improve walking capacity with a program to encourage more daily walking.


Options:
A: Arm Label: Control group; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Follow-up control group | Arm Label: Aerobic exercise group; Type: EXPERIMENTAL; Interventions: Behavioral: Aerobic exercise group, Behavioral: Follow-up first aerobic exercise group, Behavioral: Follow-up second aerobic exercise group | Arm Label: Follow-up first aerobic exercise group; Type: EXPERIMENTAL; Interventions: Behavioral: Follow-up first aerobic exercise group | Arm Label: Follow-up control group; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Control group, Behavioral: Follow-up control group | Arm Label: Follow-up second aerobic exercise group; Type: EXPERIMENTAL; Interventions: Behavioral: Follow-up second aerobic exercise group | Intervention Type: BEHAVIORAL; Name: Aerobic exercise group; Assigned to Arm(s): Aerobic exercise group | Intervention Type: BEHAVIORAL; Name: Control group; Assigned to Arm(s): Follow-up control group | Intervention Type: BEHAVIORAL; Name: Follow-up first aerobic exercise group; Assigned to Arm(s): Aerobic exercise group, Follow-up first aerobic exercise group | Intervention Type: BEHAVIORAL; Name: Follow-up control group; Assigned to Arm(s): Control group, Follow-up control group | Intervention Type: BEHAVIORAL; Name: Follow-up second aerobic exercise group; Assigned to Arm(s): Aerobic exercise group, Follow-up second aerobic exercise group
B: Arm Label: FAST+SAM; Type: EXPERIMENTAL; Interventions: Behavioral: FAST+SAM | Arm Label: FAST alone; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: FAST alone | Arm Label: SAM alone; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: SAM alone | Intervention Type: BEHAVIORAL; Name: FAST alone; Assigned to Arm(s): FAST alone | Intervention Type: BEHAVIORAL; Name: FAST+SAM; Assigned to Arm(s): FAST+SAM | Intervention Type: BEHAVIORAL; Name: SAM alone; Assigned to Arm(s): SAM alone
C: Arm Label: Prevention treatment group; Type: EXPERIMENTAL; Interventions: Behavioral: Prevention program for stroke | Arm Label: Standard treatment group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Prevention program for stroke; Assigned to Arm(s): Prevention treatment group
D: Arm Label: Care Management+Community Health Worker; Type: EXPERIMENTAL; Interventions: Behavioral: Care Management+Community Health Worker | Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual Care | Intervention Type: BEHAVIORAL; Name: Care Management+Community Health Worker; Assigned to Arm(s): Care Management+Community Health Worker | Intervention Type: BEHAVIORAL; Name: Usual Care; Assigned to Arm(s): Usual Care

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: Stroke survivors, as a group, are extremely inactive and this has serious consequences for them, including an increased risk of a second stroke and developing other diseases. This study investigates a novel intervention designed to improve everyday activity after stroke by combining walking training to improve walking capacity with a program to encourage more daily walking.


Options:
A: Arm Label: Aerobic treadmill training; Type: EXPERIMENTAL; Interventions: Other: Aerobic treadmill training | Arm Label: Control (overground walking); Type: SHAM_COMPARATOR; Interventions: Other: Control (overground walking) | Intervention Type: OTHER; Name: Aerobic treadmill training; Assigned to Arm(s): Aerobic treadmill training | Intervention Type: OTHER; Name: Control (overground walking); Assigned to Arm(s): Control (overground walking)
B: Arm Label: FAST+SAM; Type: EXPERIMENTAL; Interventions: Behavioral: FAST+SAM | Arm Label: FAST alone; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: FAST alone | Arm Label: SAM alone; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: SAM alone | Intervention Type: BEHAVIORAL; Name: FAST alone; Assigned to Arm(s): FAST alone | Intervention Type: BEHAVIORAL; Name: FAST+SAM; Assigned to Arm(s): FAST+SAM | Intervention Type: BEHAVIORAL; Name: SAM alone; Assigned to Arm(s): SAM alone
C: Arm Label: Experimental; Type: EXPERIMENTAL; Interventions: Other: Ballistic Strength Training | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual Care Physiotherapy | Intervention Type: OTHER; Name: Ballistic Strength Training; Assigned to Arm(s): Experimental | Intervention Type: OTHER; Name: Usual Care Physiotherapy; Assigned to Arm(s): Control
D: Arm Label: Standard Care; Type: PLACEBO_COMPARATOR; Interventions: Other: Standard care | Arm Label: Standard Care + VEM; Type: EXPERIMENTAL; Interventions: Other: Standard Care + VEM | Intervention Type: OTHER; Name: Standard Care + VEM; Assigned to Arm(s): Standard Care + VEM | Intervention Type: OTHER; Name: Standard care; Assigned to Arm(s): Standard Care

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Trial of Magnesium Sulfate in Obese Preeclamptic Women
Brief Summary: The purpose of this study is to learn how medications participant will receive in the course of their delivery are metabolized (broken down by the body). The investigators hope to learn more about the way drugs are metabolized by pregnant women, and how those drugs are distributed in the blood and body compartments and cleared in the urine, and how maternal body weight affects the metabolism. With this information the investigators will be able to develop a treatment regimen considering factors in the body that affect magnesium levels so that the investigators can improve treatment of pregnant women. The goal of the study is to understand how different dosing of magnesium sulfate affects blood levels of the magnesium in larger women.


Options:
A: Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 1; Type: EXPERIMENTAL; Interventions: Device: SpringFusor Pump | Intervention Type: DEVICE; Name: SpringFusor Pump; Assigned to Arm(s): 1
B: Intervention Type: DRUG; Name: abbreviation of magnesium sulfate therapy (12 hours versus the traditional 24 hours after delivery); Assigned to Arm(s): N/A
C: Arm Label: MgSO4 4g load, 1g/hr infusion; Type: ACTIVE_COMPARATOR; Interventions: Drug: Magnesium sulfate 4g loading dose, 1g/hr infusion | Arm Label: MgSO4 6g load, 2g/hr infusion; Type: EXPERIMENTAL; Interventions: Drug: Magnesium sulfate 6g loading dose, 2g/hr infusion | Intervention Type: DRUG; Name: Magnesium sulfate 4g loading dose, 1g/hr infusion; Assigned to Arm(s): MgSO4 4g load, 1g/hr infusion | Intervention Type: DRUG; Name: Magnesium sulfate 6g loading dose, 2g/hr infusion; Assigned to Arm(s): MgSO4 6g load, 2g/hr infusion
D: Arm Label: IV; Type: ACTIVE_COMPARATOR; Interventions: Other: IV administration, Drug: Magnesium Sulfate | Arm Label: Springfusor; Type: EXPERIMENTAL; Interventions: Device: Springfusor infusion pump, Drug: Magnesium Sulfate | Intervention Type: DEVICE; Name: Springfusor infusion pump; Assigned to Arm(s): Springfusor | Intervention Type: OTHER; Name: IV administration; Assigned to Arm(s): IV | Intervention Type: DRUG; Name: Magnesium Sulfate; Assigned to Arm(s): IV, Springfusor

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Communication About Uncertainty and Hope: A Randomized Controlled Trial Assessing the Efficacy of a Communication Skills Training Program for Physicians Caring for Cancer Patients
Brief Summary: Background: Although previous studies have reported the efficacy of communication skills training programs (CST), specific training addressing communication about uncertainty and hope in oncology has not yet been studied. This paper describes the study protocol of a randomized controlled trial assessing the efficacy of a CST program aimed at improving physician ability to communicate about uncertainty and hope in encounters with cancer patients.

Methods: Physician participants will be randomly assigned in groups (n = 3/group) to a 30-hour CST program (experimental group) or to a waiting list (control group). The training program will include learner-centered, skills-focused, practice-oriented techniques. Training efficacy is assessed in the context of an encounter with a simulated advanced stage cancer patient at baseline and after the CST for the experimental group, and after four months for the waiting-list group. Efficacy assessments will include communicational, psychological and physiological measures. Group-by-time effects will be analyzed using a generalized estimating equation (GEE). A power analysis indicated that a sample size of 60 (30 experimental and 30 control) participants will be sufficient to detect effects.

Discussion: The current study will aid in the development of effective CST programs to improve physician ability to communicate about uncertainty and hope in encounters with cancer patients.


Options:
A: Arm Label: Experimental group; Type: EXPERIMENTAL; Interventions: Behavioral: Communication skills training | Arm Label: Waiting-list group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Communication skills training; Assigned to Arm(s): Experimental group
B: Arm Label: Intervention Arm; Type: EXPERIMENTAL; Interventions: Behavioral: Training Program Intervention | Arm Label: Control Arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Training Program Intervention; Assigned to Arm(s): Intervention Arm
C: Arm Label: Shared decision-making program; Type: EXPERIMENTAL; Interventions: Other: Shared decision-making program | Arm Label: Usual care; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual Care | Intervention Type: OTHER; Name: Shared decision-making program; Assigned to Arm(s): Shared decision-making program | Intervention Type: OTHER; Name: Usual Care; Assigned to Arm(s): Usual care
D: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Communication training and coaching | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Communication training and coaching; Assigned to Arm(s): Intervention

Answer: A